Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 3/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.50 |
| ▸ | ADRA2A | P08913 | 3/20 | 0.47 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.47 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.47 |
| ▸ | TACR2 | P21452 | 2/20 | 0.47 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.47 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | SHBG | P04278 | 1/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.47 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | HSPE1 | P61604 | 1/20 | 0.47 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.47 |
| ▸ | TST | Q16762 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21084402 | 0.89 | ADRB2 (0.48) | ADRB2IGF1RALOX15CA2MIF | |
| SCHEMBL17077962 | 0.88 | ESR1 (0.54) | ESR1ESR2ADRA2ASLC6A2ADORA3 | |
| SCHEMBL16674489 | 0.83 | ADRB2 (0.49) | ESR1ADRA2ASLC6A2ADORA3TACR2 | |
| SCHEMBL13608769 | 0.82 | ADRB2 (0.47) | ADRB2IGF1RALOX15TAAR1 | |
| SCHEMBL25232794 | 0.80 | HTR3E (0.48) | ADRB2IGF1RALOX15MIFHTR3A | |
| SCHEMBL14356992 | 0.80 | TAAR1 (0.43) | ADRB2TAAR1 | |
| SCHEMBL14080940 | 0.80 | ADRB2 (0.43) | CYP3A4ADRB2MIFHTR3A | |
| SCHEMBL16212606 | 0.80 | MAOB (0.50) | ALDH1A1CYP3A4ADRB2HTR3ATDP1 | |
| SCHEMBL16212624 | 0.80 | TAAR1 (0.43) | ADRB2HTR3ATAAR1L3MBTL1 | |
| SCHEMBL13526333 | 0.79 | HTR3A (0.53) | SLC6A3MIFHTR3A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130123508-A1 | NOVEL NONLINEAR CHROMOPHORES ESPECIALLY SUITED FOR USE IN ELECTRO-OPTICAL MODULATION | ECOLE NORMALE SUPERIEURE DE LYON (FR) | 2013-05-16 | — | — | US | disclosed |
| US-20130123508-A1 | NOVEL NONLINEAR CHROMOPHORES ESPECIALLY SUITED FOR USE IN ELECTRO-OPTICAL MODULATION | ECOLE NORMALE SUPERIEURE DE LYON (FR) | 2013-05-16 | — | — | US | disclosed |
| US-20130123508-A1 | NOVEL NONLINEAR CHROMOPHORES ESPECIALLY SUITED FOR USE IN ELECTRO-OPTICAL MODULATION | ECOLE NORMALE SUPERIEURE DE LYON (FR) | 2013-05-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130123508-A1 | NOVEL NONLINEAR CHROMOPHORES ESPECIALLY SUITED FOR USE IN ELECTRO-OPTICAL MODULATION | CHRM5, CHRM1, CHRM2 | ESR1 989/4885ESR2 657/4885ADRA2A 778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.